Finance

Lists
NVRS:CNSX
Noveris Health Sciences Inc
CAD 0,065
0,00%
(0,00) 1D
16 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NVRS...
Open
CAD 0,07
High
CAD 0,07
Low
CAD 0,06
Mkt. cap
3,81 m
Avg. vol.
431,61 k
Volume
473,34 k
P/E ratio
0,03
52-wk high
CAD 3,00
52-wk low
CAD 0,06
EPS
CAD 2,52
No. of employees
3
Open
CAD 0,07
High
CAD 0,07
Low
CAD 0,06
Mkt. cap
3,81 m
Avg. vol.
431,61 k
Volume
473,34 k
P/E ratio
0,03
52-wk high
CAD 3,00
52-wk low
CAD 0,06
EPS
CAD 2,52
No. of employees
3
News stories
From web sources and news partners
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersVancouver, Brits-Columbië, Kanada
SectorPharmaceutical industry
Websitenoveris.health
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-40,14 k
-
-
32,79 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-70,57 k
5,04 k
316,29 k
669,62 k
Operating expense
-110,70 k
5,04 k
316,29 k
702,42 k
Total operating expenses
-110,70 k
5,04 k
316,29 k
702,42 k
Operating income
110,70 k
-5,04 k
-316,29 k
-702,42 k
Other non operating income
85,53 k
-417,63 k
-1,32 m
640,56 k
EBT including unusual items
73,79 k
3,16 m
-1,62 m
22,81 k
EBT excluding unusual items
73,79 k
-405,27 k
-1,62 m
-155,29 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
73,79 k
3,16 m
-1,62 m
22,81 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-26,16 k
-12,63 k
-9,90 k
Net interest expenses
-
-26,16 k
-12,63 k
-9,90 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme